So You Want To Get Lucky?
A little more than 20 years ago, 12 male volunteers were reporting the effects of a new potential angina drug to a Pfizer clinical research associate. One of the men reported an unusual finding – sustained and frequent erections. By Rob Wright  Continue Reading..
Is The U.S. Still The Biggest Pharma Game In Town?
I recently had a discussion with an EU-based pharma company executive. What was interesting was how this person consistently referred to the U.S. as North America and NAFTA. By Rob Wright  Continue Reading..
Is The Pharma Drug Lobby Broken?
Over the holidays, I took the time to read the Washington Post, Friday (12/28/12). Several articles caught my attention — the fiscal cliff, increased utilization of tablets and e-readers, and how the potential dock strike could cripple U.S. trade. By Rob Wright  Continue Reading..
Going Where The Problem Is – Insights From FDA/CMS Summit
If you want to make a difference in this world, you need to go where the problem is. This lesson was shared with me by the CEO of Celgene, Bob Hugin, at this year’s FDA/CMS Summit in Washington, D.C. Hugin, the chairman-elect of the Pharmaceutical Research and  Manufacturers of America (PhRMA), walked up to me prior to giving his keynote address on Tuesday, and gave me a quick education in problem solving. By Rob Wright  Continue Reading..
A CEO’s Point Of View On Developing People
If you had the chance to have an informal discussion with the CEO of a publicly traded company doing business in the life science sector, what would you ask? I get to have these discussions on a somewhat regular basis. By Rob Wright  Continue Reading..
3 Keys To Building A High Performance Team
Any good leader will tell you that they couldn’t do their job without being surrounded by a high performance team. In the hustle and bustle of getting through the daily grind, we tend to lose sight of the important role our teams play in our success, and we in theirs. By Rob Wright  Continue Reading..
Don’t Make This Pharmaceutical Outsourcing Mistake
I recently traveled to the corporate HQ of Albany Molecular Research, Inc. (AMRI) to meet with CEO, Tom D’Ambra. He founded this contract research and manufacturing organization back in 1991, before outsourcing was all the rage. By Rob Wright  Continue Reading..
The Dos And Don’ts Of Linking Your Pharma Blog
One of the key aspects of every good blog post is the liberal use of links throughout the post itself. Each link provides supporting content to the post and, in turn, makes your post more valuable. By Rob Wright  Continue Reading..
How To Handle Reader Comments To Your Biotech Blog
One of the primary goals of a blog post is to attract comments from readers. As a life science executive, you should know if your time creating a blog post is time well spent. By Rob Wright  Continue Reading..
Give Me 5 Minutes And I Will Get Readers To Your Blog
If you want readers to show up and read your life science executive blog, you need a good title, what publishers refer to as a “headline.” By Rob Wright  Continue Reading..
Rob Wright author page

Rob Wright

Rob Wright was chief editor of Life Science Leader magazine from 2011-2021. Prior to joining the publication, he spent nearly 20 years in the pharmaceutical industry. During his industry career, Wright conducted well over 1,000 presentations and roundtable discussions, including the facilitation of FDA-mandated clinical training programs for hundreds of licensed healthcare providers. He has chaired, moderated, and served as a speaker at industry and academic conferences, and served as co-chair for the 2015 and 2018 BIO International conference’s educational planning committee. Wright’s 500+ published articles have appeared in peer-reviewed academic journals, B2B magazines and online publications. He received a B.S. in Business Administration from Indiana University of Pennsylvania, MBA with distinction from Gannon University, and completed his doctoral coursework in marketing at Cleveland State University. He is a member of international business honor societies Sigma Beta Delta and Beta Gamma Sigma. He can be followed on Twitter @RfwrightLSL